HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $41,000 | +32.3% | 3,150 | 0.0% | 0.03% | +22.7% |
| Q4 2016 | $31,000 | -18.4% | 3,150 | 0.0% | 0.02% | -18.5% |
| Q3 2016 | $38,000 | +40.7% | 3,150 | 0.0% | 0.03% | +35.0% |
| Q2 2016 | $27,000 | -10.0% | 3,150 | 0.0% | 0.02% | -13.0% |
| Q1 2016 | $30,000 | -28.6% | 3,150 | 0.0% | 0.02% | +9.5% |
| Q3 2015 | $42,000 | -40.8% | 3,150 | 0.0% | 0.02% | -38.2% |
| Q2 2015 | $71,000 | +57.8% | 3,150 | 0.0% | 0.03% | +54.5% |
| Q1 2015 | $45,000 | – | 3,150 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |